Page: 3 Per Page: 10 Total Results: 249

https://investor.myriad.com/news-releases/news-release-detail/11646/

Myriad Publishes myRisk Hereditary Cancer Study in Cancer

Sep 3, 2014 ... ... BRCA1/2 testing, and 377 patients with a personal and family history who previously tested negative for BRCA mutations. Deleterious ...

https://investor.myriad.com/news-releases/news-release-detail/21111/

Myriad Seeks Japanese Regulatory Approval for its BRACAnalysis ...

Mar 30, 2020 ... ... BRCA1 and BRCA2 mutations and may be candidates for targeted therapy with the PARP inhibitor, Lynparza® (olaparib), subject to regulatory ...

https://investor.myriad.com/news-releases/news-release-detail/11611/

News Release - Investor relations - Myriad Genetics

Sep 10, 2007 ... "The risks of breast and ovarian cancers are very high in individuals carrying mutations in either the BRCA1 or BRCA2 genes. Through a blood ...

https://investor.myriad.com/news-releases/news-release-detail/11856/

Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ...

May 29, 2015 ... Myriad myRisk Finds >60 Percent More Mutations Than BRCA1/2 Testing in Multiple Studies.

https://myriad.com/genetic-tests/mychoicecdx-tumor-test/

MyChoice® CDx HRD Companion Diagnostic Test - Myriad Genetics

Tumor BRCA1/BRCA2 status; Interpretation of any tumor BRCA1 and BRCA2 variants identified; Overall test interpretation most relevant to patient management (if ...

https://myriad.com/patients-families/disease-info/ovarian-cancer/

Hereditary Ovarian Cancer | Myriad Genetics

Has had a previously identified BRCA1, BRCA2 or other gene mutation in the family. Using Hereditary Cancer Testing to Reduce Your Risk of Ovarian Cancer. If the ...

https://investor.myriad.com/news-releases/news-release-detail/?newsItemId...

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as ...

Mar 11, 2022 ... More patients with breast cancer now potentially qualify for BRCA testing.” BRACAnalysis CDx is intended to detect and interpret germline BRCA1 ...

https://myriad.com/healthcare-professionals/disease.../breast-cancer/

Hereditary Breast Cancer - Myriad Genetics

Myriad offers genetic testing that can be used to identify patients who are carriers of a BRCA1, BRCA2 or other gene mutation.

https://investor.myriad.com/news-releases/news-release-detail/?newsItemId...

News Release - Investor relations - Myriad Genetics

Aug 25, 2022 ... BRACAnalysis Diagnostic System is designed to detect and interpret germline BRCA1 and BRCA2 variants. The test identifies deleterious or ...

https://investor.myriad.com/news-releases/news-release-detail/11331/

Myriad and Abbott Enter Into Cooperative Agreement

Oct 26, 2010 ... BRACAnalysis is an analysis of the BRCA1 and BRCA2 genes developed by ... BRCA1 and BRCA2 mutation testing in connection with Abbott ...

Any more questions? We are here for you!